These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 20922572)

  • 41. Tolerance and cancer: mechanisms of tumor evasion and strategies for breaking tolerance.
    Mapara MY; Sykes M
    J Clin Oncol; 2004 Mar; 22(6):1136-51. PubMed ID: 15020616
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tumor cell recognition by the NK cell activating receptor NKG2D.
    Bryceson YT; Ljunggren HG
    Eur J Immunol; 2008 Nov; 38(11):2957-61. PubMed ID: 18979516
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Human embryo immune escape mechanisms rediscovered by the tumor.
    Ridolfi L; Petrini M; Fiammenghi L; Riccobon A; Ridolfi R
    Immunobiology; 2009; 214(1):61-76. PubMed ID: 19159828
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fas (Apo-1, CD95) receptor expression in childhood astrocytomas. Is it a marker of the major apoptotic pathway or a signaling receptor for immune escape of neoplastic cells?
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    In Vivo; 1999; 13(4):357-73. PubMed ID: 10586378
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Imaging the immune response to monitor tumor immunotherapy.
    Wang Q; Ornstein M; Kaufman HL
    Expert Rev Vaccines; 2009 Oct; 8(10):1427-37. PubMed ID: 19803763
    [TBL] [Abstract][Full Text] [Related]  

  • 46. How regulatory CD25(+)CD4(+) T cells impinge on tumor immunobiology? On the existence of two alternative dynamical classes of tumors.
    Leon K; Garcia K; Carneiro J; Lage A
    J Theor Biol; 2007 Jul; 247(1):122-37. PubMed ID: 17412365
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Targeting costimulatory pathways for tumor immunotherapy.
    Ward RC; Kaufman HL
    Int Rev Immunol; 2007; 26(3-4):161-96. PubMed ID: 17558743
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cancer and pregnancy share similar mechanisms of immunological escape.
    Wilczyński JR
    Chemotherapy; 2006; 52(3):107-10. PubMed ID: 16612052
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cancer immunology for the clinician.
    Weiner LM
    Clin Adv Hematol Oncol; 2015 May; 13(5):299-306. PubMed ID: 26352774
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cancer immunotherapy: accomplishments to date and future promise.
    Helmy KY; Patel SA; Nahas GR; Rameshwar P
    Ther Deliv; 2013 Oct; 4(10):1307-20. PubMed ID: 24116914
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CANCER IMMUNOLOGY. The "cancer immunogram".
    Blank CU; Haanen JB; Ribas A; Schumacher TN
    Science; 2016 May; 352(6286):658-60. PubMed ID: 27151852
    [No Abstract]   [Full Text] [Related]  

  • 52. Cancer biology.
    Cree IA
    Methods Mol Biol; 2011; 731():1-11. PubMed ID: 21516393
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The pattern recognition receptor-mediated immune tolerance is involved in tumor metastasis].
    Hu ZW; Yang HZ
    Sheng Li Ke Xue Jin Zhan; 2010 Feb; 41(1):5-10. PubMed ID: 21417007
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Strategies of tumor immune evasion.
    Seliger B
    BioDrugs; 2005; 19(6):347-54. PubMed ID: 16392887
    [TBL] [Abstract][Full Text] [Related]  

  • 55. T-cell immunometabolism against cancer.
    Jiang S; Yan W
    Cancer Lett; 2016 Nov; 382(2):255-258. PubMed ID: 27664755
    [TBL] [Abstract][Full Text] [Related]  

  • 56. miR-210 and hypoxic microvesicles: Two critical components of hypoxia involved in the regulation of killer cells function.
    Noman MZ; Janji B; Berchem G; Chouaib S
    Cancer Lett; 2016 Sep; 380(1):257-62. PubMed ID: 26523672
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vascular Microenvironment, Tumor Immunity and Immunotherapy.
    Lamplugh Z; Fan Y
    Front Immunol; 2021; 12():811485. PubMed ID: 34987525
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oncogenic growth factor signaling mediating tumor escape from cellular immunity.
    Concha-Benavente F; Ferris RL
    Curr Opin Immunol; 2017 Apr; 45():52-59. PubMed ID: 28208102
    [TBL] [Abstract][Full Text] [Related]  

  • 59. From tumor cell metabolism to tumor immune escape.
    Villalba M; Rathore MG; Lopez-Royuela N; Krzywinska E; Garaude J; Allende-Vega N
    Int J Biochem Cell Biol; 2013 Jan; 45(1):106-13. PubMed ID: 22568930
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Novel avenues in immunotherapies for colorectal cancer.
    Pardieck IN; Jawahier PA; Swets M; van de Velde CJ; Kuppen PJ
    Expert Rev Gastroenterol Hepatol; 2016; 10(4):465-80. PubMed ID: 26582071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.